ライフサイエンスコーパス: serology

1 endently expressed antibodies (non-canonical serologies).

2 tigens compromises Chlamydia (C.) pneumoniae serology.

3 infections by real-time RT-PCR (rRT-PCR) and serology.

4 n before the introduction of celiac-specific serology.

5 negative pretransplant HBc, HCV, EBV, or CMV serology.

6 ase chain reaction of nasopharyngeal swab or serology.

7 seroresponses were determined with multiplex serology.

8 compared to patients with no LB and negative serology.

9 time-consuming and potentially inconclusive serology.

10 ) tested positive by RT-PCR and 62 (3.1%) by serology.

11 0.86 infections per child-year by stool and serology.

12 ease by rapid test and received confirmatory serology.

13 ith acute wheezing were analyzed by means of serology.

14 104 samples) for anti-phenolic glycolipid I serology.

15 evidenced by assessment of culture, PCR, and serology.

16 Post-mortem blood was tested by serology.

17 y anaemia and was comparable to conventional serology.

18 his method was compared with standard 2-tier serology.

19 and respiratory samples and was positive on serology.

20 mples tested were positive on immunoglobin G serology.

21 ed factors associated with positive anti-HBs serology.

22 ainty in the diagnostic performance of TgERP serology.

23 All samples tested were positive on IgG serology.

24 e presence of canonical and/or non-canonical serologies.

25 clinical signs and less frequent LB positive serologies.

26 ated with survival in the oropharynx (HR for serology, 0.16; 95% CI, 0.03-0.47; for p16 measures, 0.1

27 ering all head and neck cancer cases (HR for serology,0.49; 95% CI, 0.23-1.04; for p16, 0.65; 95% CI,

28 in patients with no clinical LB and positive serology (15.3%), higher in patients with clinical LB wi

29 By serology, 16 of 121 children (13.2%) had acute HBoV1 inf

30 with clinical LB with positive and negative serology (19.3% and 20.9% respectively), and highest in

31 ally contaminated, 10 (10.2%) had a positive serology, 22 (22.5%) had an endothelial cell count < 200

32 in patients with no clinical LB and negative serology (29.3%).

33 were influenza-positive by both rRT-PCR and serology, 58 (3%) were positive by rRT-PCR-only, and 102

34 y-positive participants, 22 were positive by serology (95.7% sensitivity) and 21 were positive by the

35 Among 156 cases identified by single-point serology, adjusted VE was -55% (-177% to 13%).

36 Among 156 cases identified by single-point serology, adjusted VE was -55% (-177-13%).

37 Applying detailed serology, advanced FACS analysis, and systems biology, w

38 e used to identify individuals with positive serology against the coronavirus.

39 As determined by serology, all females caged with C. muridarum-inoculated

40 V-2, which can lead to false-positive dengue serology among COVID-19 patients and vice versa.

41 ed by negative results from immunoglobulin E serology analysis and skin tests for common food antigen

42 en-containing diet, along with findings from serology analysis.

43 e, race, disease location, and antimicrobial serologies and provided a sensitivity of 66% (95% CI 51-

44 tive follow-up to determine clinical status, serologies and serum/feces HEV RNA every 4 months.

45 igh frequency in mothers with brain-reactive serology and a child with ASD, and further demonstrated

46 es are frequent in women with brain-reactive serology and a child with ASD.

47 dies from blood of women with brain-reactive serology and a child with ASD.

48 accharide O-antigen synthesis and Weil-Felix serology and alter outer-membrane protein assembly.

49 s population easily identifiable by maternal serology and amenable to prevention messages.

50 s were determined using pseudovirion-Luminex serology and anogenital HPV DNA using Linear Array.

51 invasive candidiasis, and the application of serology and antigen testing in the diagnosis of the end

52 80% were asymptomatic and exhibited negative serology and appropriate GFD adherence based on the ques

53 ed, as it may reduce the sensitivity of both serology and biopsy testing.

54 l laboratory (Karius Inc.) was compared with serology and blood PCR in 40 patients with physician-dia

55 ase was established applying celiac-specific serology and duodenal histology, while one case was reve

56 stories derived by recall, HBRs, and measles serology and estimated true measles vaccine coverage.

57 B. mandrillaris serology and immunohistochemistry for free-living amoeba

58 of infection with an EBV-like virus based on serology and infant histopathology similar to pulmonary

59 A combination of HBoV1 serology and nasopharyngeal DNA quantitative PCR and mRN

60 In a subset of 162 patients with both HPV serology and p16 immunohistochemical (IHC) measures avai

61 often by PCR testing of other body fluids or serology and plaque-reduction neutralization testing.

62 Consecutive OT patients with positive serum serology and positive western blot (WB) on ocular sample

63 Blood was drawn for HTLV-1 serology and proviral load (PVL).

64 view, and laboratory testing including mumps serology and RT-PCR.

65 cytokine immune profile, SARS-CoV-2-specific serology and salivary antibody responses in a family of

66 mples, along with anti-phenolic glycolipid I serology and skin tests from the same individual, from 1

67 ase is achieved by combining coeliac disease serology and small intestinal mucosal histology during a

68 In addition to immunoglobulin (Ig)G and IgM serology and traditional reverse-transcription polymeras

69 and/or the presence of a concordant positive serology and urine POC-CCA test, which we consider to be

70 The combination of serology and urine POC-CCA testing detected all 23 micro

71 tive protein, tuberculin skin test, syphilis serology, and chest radiograph) followed by more complex

72 mbining conventional diagnostics (histology, serology, and clinical data) and molecular evaluation wi

73 nal test modalities (nucleic acid detection, serology, and culture) take hours to days.

74 amples prepared by sedimentation technique], serology, and point-of-care circulating cathodic antigen

75 gative immunoglobulin G (IgG)-IgM SARS-CoV-2 serology, and positive RNAemia measured by digital polym

76 Baseline CMV serology, and STI-incidence/-seroprevalence, sexual and

77 ) tested positive by RT-PCR and 92 (4.6%) by serology; and for AdV, 111 (5.5%) tested positive by RT-

78 er age at presentation, small bowel disease, serology (anti-Saccharomyces cerevisiae antibody, antifl

79 e association between 15 different multiplex serology antigens and the risk of gastric cardia (GCA) a

80 ive for S stercoralis in faecal tests and on serology (any titre) or had a positive serological test

81 a readily available bead array platform for serology applications is feasible.

82 Using a systems serology approach we also demonstrate that anti-spike ne

83 Using a systems serology approach, we demonstrate higher levels of SARS-

84 Serologies are the standard means of diagnosis in the la

85 Taken together, PCR and serology are complimentary modalities that require time-

86 T-qPCR in multiple diagnostic specimens, and serology are essential to ensure an accurate diagnosis o

87 le, automated, multiplexed, quantitative HBV serology assay platform we designed shows great promise

88 p included recommendations for (1) advancing serology assays as a tool to better understand SARS-CoV-

89 Serology assays can detect EBOV-specific antigens and an

90 We conclude that standardization of EBV serology assays is needed to allow for comparability of

91 omparisons across a range of established EBV serology assays, we created a panel of 66 pooled serum s

92 gnificantly better clinical sensitivity than serology assays.

93 Here we explore how individual serologies associated with RA drive associations within

94 (TESA)-blots at birth and 1 month and by IgG serology at 6 and 9 months.

95 month by microscopy, PCR and immunoblot, and serology at 6 and 9 months.

96 Interpretation of Toxoplasma serology at a reference laboratory can help differentiat

97 ed at diagnosis were classified according to serology at diagnosis: IgG negative (-) (nonimmune), IgM

98 Measles detection in CSF was performed by serology at the California Department of Public Health o

99 Group 1: pre-endoscopy serology availability was retrospectively analysed in a

100 directed serological testing (i.e., Q fever serology, Bartonella serology) in culture-negative cases

101 We propose that an individualized serology-based approach to MN, used to complement and re

102 Thus, existing 2-tier serology-based assays yield low sensitivities (29%-40%)

103 e laboratory confirmation of Lyme disease is serology-based diagnostics.

104 and investigate the discriminatory power of serology-based elimination thresholds.

105 it is possible to assess HPV infection using serology-based methods; however, the suitability of this

106 The replacement of traditional serology-based typing of Escherichia coli by WGS is supp

107 tivity and T-cell activation by means of IgE serology, basophil activation testing, T-cell proliferat

108 Faecal calprotectin, thyroid tests, celiac serology, breath tests were more frequently suggested in

109 atient was confirmed as having positive Lyme serology by reference laboratory testing, and there was

110 Serology can be a helpful adjunct to RT-PCR for research

111 ion of sensitivities over time indicate that serology can function as a reliable diagnostic aid indic

112 nsider COVID-19 due to false-positive dengue serology can have serious implications.

113 The clinical significance of discordant serology (CIA(+)/RPR(-)) for maternal and neonatal outco

114 tiology, tularemia was diagnosed by advanced serology consisting of two-dimensional Western-immunoblo

115 f tightly co-occurring antibodies (canonical serologies, containing CCP2), along with several indepen

116 i-TgERP antibodies indicates that anti-TgERP serology could be a useful tool for delineating T. gondi

117 The human and ferret serology data suggest that a single dose of the vaccine

118 Compared with serology, DNA PCR had high clinical sensitivity (100%) b

119 on ventilator, recipient hepatitis C virus + serology, donor age and cold ischemic time.

120 ents with nonspecific symptoms with negative serology during the acute phase.

121 In this study, serology (ELISA) and molecular techniques (PCR/qPCR) wer

122 TcI-specific serology facilitates investigation between lineage and d

123 S-CoV-2 infection and (2) conducting crucial serology field studies to advance an understanding of im

124 Serology findings were negative for celiac disease.

125 of available evidence supporting the use of serology for either diagnosis or epidemiology was, howev

126 Our subgroup analysis in studies using only serology for HPV detection showed a significant associat

127 ed a possible association with fibroids, and serology for HSV-2 is much more sensitive than self-repo

128 sive inflammation with normal hematology and serology for inflammatory markers three months after sca

129 ratory tests, 7 functional scales, reference serology for Lyme disease using Centers for Disease Cont

130 False-positive serology for Lyme disease was reported in patients with

131 Serology for MWPyV VP1 indicates that infection frequent

132 atients; 7 male) with dengue fever (positive serology for NS1 antigen) were enrolled in the study.

133 e Control and Prevention criteria, reference serology for other tick-associated pathogens, and cytoki

134 as no difference in distribution of positive serology for other tick-transmitted pathogens or cytokin

135 correlated and the added diagnostic value of serology for respiratory viruses other than influenza vi

136 y immunoblot, with that of standard 2-tiered serology for the diagnosis of Lyme disease.

137 -time reverse transcription-PCR (RT-PCR) and serology for the diagnosis of respiratory syncytial viru

138 e by RT-PCR and 234 (11.6%) were positive by serology; for HMPV, 172 (8.5%) tested positive by RT-PCR

139 tested positive by RT-PCR and 147 (7.3%) by serology; for the PIVs, 94 (4.6%) tested positive by RT-

140 Despite rare detection of EV RNA, pan-viral serology frequently identified high levels of CSF EV-spe

141 ual-level mechanistic models to longitudinal serology from children and adults.

142 ted numbers of lifetime sex partners and HPV serology from the National Health and Nutrition Examinat

143 We analyzed differences in serology, gastroscopic manifestations and pathology betw

144 d by bronchoalveolar lavage, lung histology, serology, gene expression in lung tissue, and measuremen

145 Best Practice Advice 10: Celiac serology has a guarded role in the detection of continue

146 Serology has become an increasingly important tool for t

147 ERP IgG will help to determine whether TgERP serology has epidemiological utility for quantifying the

148 Helicobacter pylori antigens using multiplex serology have not been consistent across studies.

149 Genotypes, antimicrobial serologies, ileal gene expression, and ileal, rectal, an

150 lobulin therapy; prospective analysis of HBV serology in 16 patients commencing intravenous immunoglo

151 eaction (RT-PCR) analysis in 17 cases and by serology in 6 cases.

152 performed a cross-sectional analysis of HBV serology in 80 patients established (>6 months) on immun

153 d by real-time reverse transcription PCR and serology in a community-based cohort study that follows

154 in particular as to sensitivity, as negative serology in a treated patient does not guarantee that th

155 thesis: 1) the availability of pre-endoscopy serology in anaemia; 2) the sensitivities and cost effec

156 ed hepadnavirus based on virus detection and serology in any deltavirus-positive animal.

157 commends monitoring Onchocerca volvulus Ov16 serology in children aged <10 years for stopping mass iv

158 International guidelines recommend coeliac serology in iron deficiency anaemia, and duodenal biopsy

159 NA1) was measured using bead-based multiplex serology in plasma samples from 8,746 MS cases and 7,228

160 testing (i.e., Q fever serology, Bartonella serology) in culture-negative cases.

161 n with SAG1 may strengthen Toxoplasma gondii serology, in particular in seroepidemiological studies.

162 of the 38 (29%) cases had positive syphilis serology, including four (36%) with neurosyphilis.

163 t number of positive detections overall, but serology increased diagnostic yield for RSV (by 11.8%),

164 t that this simple intradermal-administered, serology-independent approach is likely important for ad

165 The interpretation of serologies is confounded by antibody cross-reactivity wi

166 Best Practice Advice 1: Serology is a crucial component of the detection and dia

167 Serology is cross-reactive, laborious, and frequently di

168 Serology is essential for Q fever diagnostics, a disease

169 Convalescent-phase serology is impractical, blood culture is slow, and many

170 Serology is insensitive during the first days to weeks o

171 timate from cases identified by single titre serology is misclassification arising from limited diagn

172 timate from cases identified by single-titer serology is misclassification arising from limited diagn

173 However, pre-endoscopy serology is often unavailable, thus committing endoscopi

174 D with clinical background and extract-based serology is superior to CRD alone in assessing the risk

175 Whilst pathogen serology is typically performed by centralized laborator

176 mended in infants <18 months of age, in whom serology is unreliable.

177 tly challenging with no validated commercial serology kits available.

178 d to Palo Alto Medical Foundation Toxoplasma Serology Laboratory (PAMF-TSL) to determine whether the

179 the Palo Alto Medical Foundation Toxoplasma Serology Laboratory (PAMF-TSL).

180 To date, many serology LFAs have been developed, though none meet the

181 either by whole-cell ELISA test or multiplex serology, likely due to the high prevalence of seroposit

182 w of the coronavirus disease 2019 (COVID-19) serology literature and construct best practice guidance

183 Donor age, obesity, alcohol abuse, hepatitis serology, liver only donor, imaging results, and transpl

184 87% correctly, making Cor a 14 the superior serology marker.

185 atform for the measurement of a panel of HBV serology markers, including HBV "e" antigen (HBeAg), HBV

186 Standard commercial HIV serology may be a practical initial indirect measure of

187 Using Simoas, serology may be used for the detection of dengue virus i

188 Hence, small-scale serology may serve as the basis for effective adaptive p

189 TgERP serology may therefore be an important epidemiological t

190 TCD; 12 were first colonized >1 month before serology measurements.

191 s drug user increased from 12.5% (4/24) with serology negative donors to 70.8% (17/24) if NAT was ava

192 ature correctly classified 77%-95% of the of serology negative Lyme disease patients.

193 sma, positive for cytomegalovirus (CMV), and serology negative.

194 The lesions in serology-negative cases were mostly small to medium (n =

195 m IgA and IgM compared to controls, based on serology of larger cohorts (n = 3494 IgA; n = 397 IgM).

196 While most isolates exhibited the accepted serology of serotype 35B, one isolate failed to bind to

197 Systems serology of the antibody responses identifies plasma ant

198 t the mutant WciG was nonfunctional, and the serology of the mutant could be restored through complem

199 dy-based vaccine strategies, termed "systems serology", offers an unbiased and comprehensive approach

200 ividuals who were positive for non-canonical serologies (omnibus_p = 9.2 x 10(-17)).

201 and 2, human herpesvirus 8) using multiplex serology on blood samples collected at birth (cord blood

202 Trichinella serology on patient sera as well as polymerase chain rea

203 respiratory and environmental specimens, and serology on sera from employees at beginning and end of

204 We show the impact of updated serology on these patients.

205 rRT-PCR-only, and 102 (5%) were positive by serology only.

206 dence of the infection in several tissues by serology or polymerase chain reaction.

207 shi or R. typhi rapid diagnostic test (RDT), serology, or PCR.

208 alities, polymerase chain reaction (PCR) and serology, over the disease course to provide insight int

209 elated with the number of positive canonical serologies (p = 0.0096).

210 already have confirmative diagnosis using a serology, pericardial effusion analysis or biopsy.

211 ce interval, 82.2%-100%), the combination of serology plus urine POC-CCA testing appears to be the mo

212 d 216 patients (72 per arm); 158 (73.2%) had serology/polymerase chain reaction (PCR)-confirmed murin

213 Among pregnant women with serodiscordant serologies (positive treponemal tests and a negative non

214 The lesions in Toxoplasma serology-positive cases were mostly flat to shallow (n =

215 The lesions in CMV serology-positive cases were mostly solitary (n = 8/8),

216 ty using 1,204 samples submitted for routine serology prior to COVID-19's emergence, plus 64 pandemic

217 ate and another that, based on P. falciparum serology, resembled the malaria-naive Dutch cohort.

218 2 serology results; 22% of participants with serology results had fibroids.

219 ings provide immediate clinical relevance to serology results that can be equated to NAb activity and

220 nts were classified based on clinical LB and serology results.

221 ce standard combining clinical diagnosis and serology results.

222 ticipants, 1,658 had blood samples and HSV-2 serology results; 22% of participants with serology resu

223 Using HBoV1 serology, reverse-transcription polymerase chain reactio

224 Complete blood count with differential, serology screen (including cysticercosis and echinococcu

225 are of the risk and given the opportunity of serology screening in the first trimester.

226 CMV viral load, serologies, serial spirometry, and mortality were record

227 Follow-up serology should be performed 6 and 12 months after diagn

228 irst by intestinal biopsies, celiac-specific serology should be undertaken as a confirmatory test bef

229 Array and multiplex serology showed strong correlation for each individual E

230 arning methods, we identified a parsimonious serology signature to distinguish acute typhoid cases fr

231 We describe serology specific for TcI, the predominant lineage north

232 All had connective tissue disease (CTD) serologies, spirometry, and high-resolution computed tom

233 nor, recipient, and combined donor/recipient serology status was not associated with BK viremia (P =

234 Additionally, we tested SARS-CoV-2 serology-status in patients with dengue and performed in

235 To assess dengue serology-status, we used dengue-specific antibodies by m

236 went pre-treatment S. stercoralis testing by serology, stool microscopy, and/or stool PCR.

237 Multiplex serology successfully validated the original EBV proteom

238 Two cases with slightly lower loads, in whom serology suggests the infection may have been caught ear

239 ith dengue before September 2019, SARS-CoV-2 serology targeting the S protein was positive/equivocal

240 results by both traditional biochemistry and serology (TB&S) and the kmer identification (ID) derived

241 e to cross-reactivity, a positive first-line serology test requires confirmation by either a plaque r

242 uded numbers of intraepithelial lymphocytes, serology test results (for levels of antibodies against

243 Of 5,126 patients enrolled, RT-PCR and serology test results were available for 2,023, includin

244 rate, rapid, and inexpensive alternatives to serology testing for the screening of HBV infection at f

245 Test program used combined nucleic acid and serology testing to screen for primary infection targeti

246 es reported patients' symptoms, results from serology tests, and findings from histologic analyses.

247 formance, such as a dietary questionnaire or serology tests, may be inaccurate in detecting dietary t

248 Here, we used systems serology to characterize the Fc profile of influenza-, p

249 To understand this, we used systems serology to define Fc features associated with antibody

250 k identified by proteome arrays to multiplex serology to establish an assay for large-scale studies.

251 ths in human sera, limiting the use of TgERP serology to only those patients recently exposed to T. g

252 We found a strong correlation among positive serology to recombinant proteins LinB-13, 26, 15, 21 and

253 Recent technological advances, including serology, transcriptomics, and metabolomics, have provid

254 rthern California with discordant treponemal serology underwent reflexive testing with Treponema pall

255 stematic pathogen testing included cultures, serology, urine antigen tests, and molecular detection.

256 onococcal urethritis and a negative syphilis serology using broad-range bacterial polymerase chain re

257 In comparison, sensitivity of acute-phase serology using modified two-tiered testing (MTTT) was 50

258 Persistently positive serology usually indicates ongoing intestinal damage and

259 me an important tool for structural biology, serology, vaccine design and immunology studies.

260 NGS-based serology via SERA provides an effective approach to disc

261 Viral serology, viral load, and liver biochemistry were perfor

262 has potential applications as a reagent for serology, virology and as an immunogen.

263 ve symptoms in patients with LB and positive serology was 0.71 (95% CI, .50-1.03) compared to patient

264 The prevalence of positive anti-HBs serology was 23.4%.

265 ures, 0.16; 95% CI, 0.03-0.46), whereas only serology was associated with outcome when considering al

266 In group 1, serology was available in 361 (33.8 %) patients.

267 Furthermore, an arboviral serology was done in 169 (49%) patients and measurements

268 Serology was measured at baseline, 2 and 12 months postv

269 Hepatitis A-E serology was measured, including hepatitis B e antigen,

270 Acute serology was nonreactive in all patients, though convale

271 Serology was not discriminative enough in identifying on

272 HTLV-1 serology was performed by Western blot on plasma samples

273 Serology was performed on all samples using the CDC's st

274 Systematic monitoring of MMRV serology was performed prior to transplantation and one-

275 Cytomegalovirus (CMV) serology was positive in 564 of 645 individuals (87%).

276 Coeliac disease serology was positive in all cases.

277 HIV serology was quantified by signal-to-cutoff ratio (S/CO)

278 eactive in all patients, though convalescent serology was reactive in 6 of 8 (75%) patients for whom

279 HIV/HCV serology was tested at enrollment and at 32- and 64-week

280 ned that the genetic basis for this aberrant serology was the presence of inactivating mutations in t

281 Agreement with the traditional method (serology) was also observed in all laboratories for 14 s

282 To define MHC differences for specific ACPA serologies, we quantified a total of 19 separate ACPAs i

283 Using systems serology, we assessed changes in antibody functional pro

284 Using multiplex serology, we determined the seroprevalence of 10 human P

285 Using genomics, histopathology, and serology, we found M. lepromatosis in squirrels from Eng

286 To calculate daily clinical sensitivity by serology, we utilized 157 PCR-positive patients with a t

287 revealed Bartonella quintana, and Bartonella serologies were subsequently noted to be positive.

288 thway recognition molecule MBL, and antibody serology were analyzed by enzyme-immunoassays; viral loa

289 at least a third of infections determined by serology were asymptomatic.

290 Most pregnant women with discordant serology were CIA(+)/RPR(-)/TP-PA(-); more than half who

291 th positive anti-hepatitis B surface antigen serology were excluded.

292 Two of the 44 (5%) cases tested by serology were mumps IgM positive, and 27 of the 40 (68%)

293 of pathogens detected by conventional PCR or serology were not isolated by TGC-NGS, suggesting that f

294 Among factors predicting positive anti-HBs serology were young age and higher education.

295 ere more likely to have a positive arbovirus serology, were more likely to have a positive HSV PCR, w

296 anges in antibody to HBsAg levels, and donor serology, were not associated with HBV reactivation.

297 ) diagnostic sensitivity than current 2-tier serology, while retaining high specificity.

298 As this isolate expresses a unique serology with unique biochemistry and a stable genetic b

299 ies in cases that would be defined "negative serology" with current diagnostic applications.

300 Serology yielded finding compatible with ZIKV as the cau